1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Univariate analysis for predictors of recanalization after thrombolysis
Recanalized (n = 13) Not Recanalized (n = 10) P Value Mean ipsilateral MCA CBF (ml/100 g/min) 20.2 ± 6.3 14.7 ± 5.3 .039* Mean contralateral MCA CBF (ml/100 g/min) 39.8 ± 9.5 38.5 ± 10.1 .74* Ratio 0.53 ± 0.19 0.38 ± 0.09 .019* Platelet count (×109/L) 234 ± 74 324 ± 188 .12* Age (years) 66.7 ± 12 67.7 ± 11 .69* Time-to-treatment (min) 212 ± 59 222 ± 32 .7* NIHSS 18 ± 3 17.69 ± 4 .74* Thrombus at carotid terminus Yes: 4/23 Yes: 3/23 .68† No: 9/23 No: 7/23 Mean arterial pressure (mm Hg) 102 ± 21 105 ± 17 .39* Admission glucose 141.8 ± 60 131.3 ± 50 .63† Thrombolytic modality IA: 6/23 IA: 5/23 .60† IV/IA: 7/23 IV/IA: 5/23 Antiplatelet therapy before admission Yes: 2/23 Yes: 4/23 .34† No: 11/23 No: 6/23 Stroke cause CE: 6/23 CE: 5/23 .59† Non-CE: 7/23 Non-CE: 5/23 Symptomatic hemorrhage Yes: 4 /23 Yes: 2/23 .66 No: 9/23 No: 7/23
Note:—MCA indicates middle cerebral artery; CBF cerebral blood flow; NIHSS, National Institutes of Health Stroke Score; IA, intra-arterial; IV, intravenous; CE, cardioembolic; Non-CE, noncardioembolic.
* Student t test.
† Fisher exact test.